Close Menu
Home » Qiagen Q3 Revenues Grow 1 Percent as Firm Lowers Full-Year Guidance

Qiagen Q3 Revenues Grow 1 Percent as Firm Lowers Full-Year Guidance

Oct 30, 2019
|
staff reporter

This article has been updated from a previous version to include comments made by Qiagen executives during the company's earnings call on Wednesday.

NEW YORK – Qiagen reported after the close of the market on Wednesday that its third quarter revenues increased 1 percent year over year, missing analysts' consensus estimate.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Project to Discuss Race and Genetics in Class

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

Taking It All On

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

PLOS Papers on ASD-Related Syndrome, Twin Gut Microbiomes, Zika Virus Evolution

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

Unexpected Close

GenomeWeb reports that Veritas Genetics is suspending its US operations.

What's Popular?

In Business News

  1. Roche Ending Partnership With Syapse

  2. Veritas Genetics Halts US Operations, Lays Off More Than 30

  3. Biocept Prices $10M Public Offering of Stocks, Warrants

  4. Illumina, PacBio Dispute UK Regulator's Finding That Merger Would Weaken Competition

  5. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.